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Bovine respiratory syncytial (BRS) virus can be divided into antigenic subgroups based on the reactivity of monoclonal
antibodies (mAbs) to the attachment glycoprotein, G. Further, the polyclonal antibody response of calves vaccinated with
recombinant vaccinia viruses expressing the G protein of a particular subgroup is also subgroup-specific. To investigate
the genetic basis for the antigenic heterogeneity of the BRS virus G protein, the genes for the G protein from 6 BRS virus
strains representative of the antigenic subgroups were cloned, sequenced, and compared with the prototype subgroup A
strain, 391-2. There was only 10% nucleic acid difference and 15% amino acid difference between strains from different
subgroups. These findings are in sharp contrast to the situation with human RS virus, where there is a 45% difference in
amino acid identity between subgroups. In fact, the extent of amino acid difference between BRS virus subgroups is similar
to the level of heterogeneity observed within human subgroups. Analysis of the reactivity of mAbs with peptides from the
cysteine-rich region (174–188) of the G protein representing each antigenic subgroup indicated that amino acids at positions
180, 183, and possibly 184 are important in subgroup distinction. Taken together, these data suggest that although the
genetic variation responsible for the antigenic differences determining subgroups among BRS viruses is more limited than
that observed among human RS virus subgroups, the amino acid differences that exist have a profound effect upon antibody
recognition. q 1997 Academic Press
INTRODUCTION G of BRS virus does not cross-react with antiserum to
the HRS virus G glycoprotein (Lerch et al., 1989).
Bovine respiratory syncytial (BRS) virus is an economi- Both BRS virus and HRS virus strains possess antigen-
cally significant respiratory pathogen of cattle which ically heterogenous G proteins. Numerous studies based
shares many pathological and epidemiological charac- on the antigenic reactivity of HRS virus strains with mono-
teristics with the related human pathogen, human respi- clonal antibodies (mAbs) to the G protein have demon-
ratory syncytial (HRS) virus (Stott and Taylor 1985; Baker strated two antigenic subgroups, A and B (Anderson et
1991). Both of these viruses cause bronchiolitis and al., 1985; Mufson et al., 1985). Sequence comparison of
pneumonia, which are particularly severe in the young. the G genes of representative strains of these two human
Both viruses are distributed throughout the world and RS virus subgroups indicates that the G proteins can
cause annual winter epidemics and recurrent infections. vary by as much as 47% between subgroups (Johnson
BRS virus infection in cattle is common and serological et al., 1987). In addition, within subgroup A, the G proteins
studies indicate that greater than 95% of cattle over the can vary by as much as 20% (Cane et al., 1991), while
age of 3 years have been infected and that 70% of calves within the B subgroup they can vary by as much as 9%
are infected within the first year of life (Stott and Taylor, (Sullender et al., 1991). Seroepidemiological studies have
1985). identified multiple lineages within each subgroup and
These viruses are classified as pneumoviruses within the cocirculation of more than one lineage during an
the family Paramyxoviridae. The protein composition of epidemic (Cane and Pringle, 1991; 1995; Hendry et al.,
both viruses appears to be identical (Lerch et al., 1989; 1986; Garcia et al., 1994).
Cash et al., 1977) and many BRS virus proteins cross- Although there have been fewer studies of BRS virus
react antigenically with their HRSV homologs, most nota- strains, available data suggest that there are distinct anti-
bly the structural proteins, fusion (F), phosphoprotein (P), genic subgroups of this virus as well. Initial analysis
matrix (M), and nucleocapsid (N) (Lerch et al., 1989; Or- of the BRS virus strain, 391-2, demonstrated antigenic
vell et al., 1987). However, the attachment glycoprotein differences between the G protein of this strain and that
of the BRS virus strain 127 (Lerch et al., 1989). Recently,
the antigenic characterization of BRS virus strains was1 To whom reprint requests should be addressed.
extended to 17 additional strains using polyclonal sera2 Present address: Department of Botany and Microbiology, Auburn
University, Auburn, AL 36849. and mAbs raised against the 2 strains 391-2 and 127
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TABLE 1 Lelystad strain of BRS virus (Westenbrink and Kimman,
1987) was obtained from Dr. J. van Oirschot, Lelystad,BRS Virus Strains Used in This Study
The Netherlands.
Country of Year of Antigenic
Designation origin isolation subgroup Antibodies
Thirteen murine anti-G mAbs raised against the 391-391-2a USA 1985 A
Snooka UK 1976 A 2 isolate of BRS virus and one murine anti-G mAb 70
220-69a Belgium 1969 Intermediate raised against the 127 isolate of BRS virus have been
Rispovalb SKB vaccine 1969 Intermediate
described previously (Furze et al., 1994). mAbs 75 to 79,Lelystadc Holland NK Intermediate
86 and 87 were prepared from mice inoculated intraperi-127a UK 1973 B
toneally with a recombinant vaccinia virus (rVV) express-4642a UK 1976 B
220-60a NK NK B ing the G protein of the 127 strain of BRS virus (Furze et
WBHa Holland 1986 Untyped al., unpublished results), followed by 0.2 ml of 10-fold
concentrated serum-free supernatant from CV-1 cells in-Note. NK, Not known.
fected with the 127 strain of BRS virus, as describeda Analysis of antigenic subgroups and origin of strains has been
previously (Furze et al., 1994).described previously (Furze et al., 1994).
b Rispoval vaccine strain of BRS virus was derived from strain 220- Polyclonal serum M117, which has a neutralizing titer
69 (Dr. N. Zygraich, personal communication). of 1:16 and an ELISA titer of log10 4.5 using the 127 strainc Westenbrink and Kimman (1987).
of BRS virus as antigen, was obtained from a gnotobiotic
calf immunized subcutaneously on two occasions with
an immunoprecipitation band derived from a lysate of CK(Furze et al., 1994). These results showed the presence
cells infected with the 127 strain of BRS virus and aof at least 2 antigenic subgroups of BRS virus. The G
hyperimmune calf serum, in Freund’s incomplete adju-protein of 13 strains reacted with the polyclonal serum
vant. Polyclonal serum 2106, which has a neutralizingand panel of mAbs raised against the 391-2 strain, while
titer of 1:10,000 and an ELISA titer of log10 5.1 using thethe G protein of 5 strains reacted with the serum and a
Snook strain of BRS virus as antigen, was obtained fromsingle mAb raised against the 127 strain. One strain, 220-
a gnotobiotic calf infected by intranasal and intratracheal69, exhibited intermediate reactivity, while another, WBH,
inoculation with the 391-2 strain of BRS virus on twowas unreactive with any sera or mAb. In addition, struc-
occasions, 3 weeks apart, followed by a lysate of CK cellstural differences were noted in the F proteins of the two
infected with the 391-2 strain, in Freund’s incompletesubgroups. These antigenic analyses showed the occur-
adjuvant administered subcutaneously on two occasionsrence of distinct BRS virus subgroups based on variation
3 weeks apart. Sera was also obtained from calves vacci-in the G protein. In contrast, a report comparing the G
nated 6 weeks previously with 2 1 108 PFU of rVV ex-gene sequence from only two BRSV strains with that of
pressing the G or F protein of the 391-2 strain of BRSthe 391-2 G gene demonstrated at least 90% homology
virus (Lerch et al., 1990, 1991).between these strains, leading the authors to suggest
that BRS virus is monotypic (Mallipeddi and Samal, 1993).
Isolation of viral RNA, cloning, and sequencingTo better understand the extent of variation in the G
gene and its encoded protein sequence responsible for Two synthetic oligonucleotides were used in cDNA
the antigenic differences reported by Furze et al. (1994), synthesis and amplification. Oligonucleotide 5*G (5*
we have cloned and sequenced the G genes from three CACGGATCCACAAGTATGTCCAACC 3* ) corresponds to
subgroup B strains, a second subgroup A strain, the nucleotides 10-25 of the 391-2 mRNA and is complemen-
intermediate strain 220-69, and the untyped strain WBH. tary to virion sense RNA and contains a BamHI site. The
These studies show that while these proteins are anti- second oligonucleotide 3785 (5* CACGGATCCGGCTGT-
genically distinct, the amino acid sequences of the G TGCCGCCATCC 3* ) is complementary to nucleotides 12-
proteins differed by only 15%. This variation is much 28 of the F protein open reading frame of message sense
lower than that observed between HRS virus antigenic RNA and also contains a BamHI site.
subgroups and is more similar to that reported for HRS Total cytoplasmic RNA was prepared from infected-
virus strains from within the same subgroup. cell lysates by extraction with hot phenol (Penman, 1969).
First-strand cDNA was synthesized using a single primer
MATERIALS AND METHODS and either Moloney murine leukaemia or avian myelo-
blastosis virus reverse transcriptase (Gibco BRL). Subse-Virus isolates
quently, the second strand was synthesized with Taq
polymerase (Gibco BRL) and the addition of the 5* primer.The BRS virus strains included in this study were de-
scribed previously and grouped by reactivity with hyper- The cDNAs of the expected size were isolated on low-
melt agarose gels, extracted, and ligated into pGEM3immune sera and mAbs (Table 1) (Furze et al., 1994). The
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downstream of the T7 promoter using the BamHI site. electrophoresis, the gels were fixed and soaked in 1 M
sodium salicylate for 30 min before drying. Dried gelsPlasmid DNA was sequenced using a Sequenase kit
(U.S. Biochemicals Corp.) and 35S or the Applied Biosys- were exposed to Fuji RX film at 0707.
tems Taq DyeDeoxy Terminator Cycle Sequencing kit
Peptide synthesis and ELISAsand a 373A DNA sequencer. Both strands from each of
two independant clones were sequenced for each of Four peptides corresponding to amino acids 174–188
the BRS virus strains. DNA and amino acid sequence of the G protein of the 391-2, 220-69, 127, and WBH
analyses were performed with a VAX computer and the strains of BRS virus were synthesized on an ABI 430A
University of Wisconsin Genetics Computer Group pro- peptide synthesizer using f-moc chemistry and purified
grams (Devereux et al., 1984). by reverse-phase HPLC (Table 2). Peptides were dis-
The cloning, sequencing, and expression from recom- solved in sterile distilled water, diluted in 0.1 M carbonate
binant rVV of the 391-2 G gene has been reported pre- buffer, pH 8.2, and coated onto 96-well immunosorbent
viously (Lerch et al., 1990). For expression using vTF7-3, plates (Nunc Maxisorb Flow) at 1 mg/well in 100 ml buffer.
this gene was subcloned into pGEM4 downstream of the The plates were blocked for 1 hr using 5% porcine sera
T7 promoter. in phosphate-buffered saline (PBS) containing 0.05%
Tween 20 (PS/PBS/Tw). After washing in PBS containing
Expression and immunoprecipitation of the G proteins
0.05% Tween 20 (PBS/Tw), antibodies were titrated in
from cDNA
PS/PBS/Tw. After a 1-hr incubation, the plates were
washed in PBS/Tw and peroxidase-labeled conjugatedThe G proteins from each clone were expressed in
cells using the rVV expressing T7 polymerase (vTF7-3) anti-mouse IgG (KPL) was added and the plates were
again incubated for 1 hr. After washing, bound conjugate(Fuerst et al., 1986). Semiconfluent monolayers of
HuTK0143B cells in 60-mm dishes were infected with was detected using 3,3*,5,5*-tetramethylbenzidine (TMB)
(ICN Pharmaceuticals) as substrate. ELISAs using BRSvTF7-3 at an m.o.i. of 5 PFU per cell. One hour later the
cells were transfected with 5 mg of plasmid DNA using 20 virus antigens prepared from CK cells infected with differ-
ent BRS virus strains were carried out as previously de-ml of lipofectin (Gibco BRL) in minimal essential medium
(MEM) per dish. Five hours postinfection, the medium scribed (Furze et al., 1994).
was aspirated and replaced with MEM containing 50
mCi/ml [3H]glucosamine (40 Ci/mmol; ICN). The mono- RESULTS
layers were incubated at 377 for 5 hr, at which time cyto-
Characterization of mAbs to subgroup B BRS viruses
plasmic extracts were prepared as described previously
(Wertz et al., 1989). For immunoprecipitation, aliquots Previous studies characterizing the antigenic hetero-
geneity of BRS viruses utilized a panel of 22 mAbs spe-equivalent to one-half of the lysate per dish were incu-
bated with hyperimmune sera or mAb for 90 min at room cific for subgroup A strains but only a single mAb specific
for subgroup B strains (Furze et al., 1994). In order totemperature. The antigen–antibody complexes were
then precipitated as described previously (Roberts et al., expand our analyses of the subgroup B viruses, a new
panel of mAbs raised against the subgroup B strain 1271994), with the exception that 20 ml of Protein G–Sepha-
rose (Pharmacia) was used to precipitate complexes was prepared. Hybridoma cultures secreting antibodies
that reacted with only the 127 strain and not the Snookcontaining mAbs. After washing, the samples were re-
suspended in SDS–PAGE sample buffer and analyzed strain of the BRS virus were selected for cloning. The
culture fluids of all seven of the resulting hybridomaby SDS–PAGE on 10% polyacrylamide gels. Following
TABLE 2
Sequences of Synthetic Peptides
BRSV
Subgroup strain Peptide sequence
174 180 183 184 187 188
A 391-2 S T C E G N L A C L S L C H I
Int a 220-69 S T C E G N L A C S S L C Q I
B 127 S T C E G N P A C S P L C Q I
Ub WBH S T C E G N P A C S S L C Q I
a Intermediate strain.
b Untyped strain.
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Nucleic acid sequence analysis
In order to determine the genetic basis for the anti-
genic differences in the G proteins identified by mAbs
and polyclonal sera, the nucleotide and amino acid se-
quences of the attachment glycoprotein from the BRS
virus strains 127, 4642, and 220-60 (subgroup B strains),
220-69 (an intermediate strain), Snook (a subtype A
strain), and WBH (an untyped strain) (Furze et al., 1994)
were determined. Figure 2 shows the sequences of these
strains in comparison with that of the 391-2 strain (Lerch
et al., 1990), the original subtype A strain. The first nine
nucleotides of the 5* sequence of the G mRNA were not
determined because the 5*G primer annealed to nucleo-
tides 10–25 of this region (Fig. 2). Alignment of the nucle-
otide sequences for the six strains determined in this
study with the nucleotide sequence of the 391-2 G ORF
FIG. 1. Binding of subgroup B G mAbs to BRS virus strains. The did not introduce any gaps or insertions. There were
strains of BRS virus were tested for their reactivity in an ELISA against three nucleotide deletions in the 3* noncoding region of
subgroup B G mAbs. I, intermediate strains; U, untyped strain. Patterns:
all BRS virus strains compared to the corresponding re-More than 50% (Ò) and less than 25% (`) of the values obtained for
gion of strain 391-2. Strains 220-69, 391-2, and Snookeach antibody against the 127 strain of BRS virus.
had the first termination codon (UAA, UAG, and UAA
respectively) at position 787–789, while strains 127,clones recognized the G protein of the 127 strain of BRS
4642, 220-60, and WBH had the termination codon (UAA)virus by radioimmunoprecipitation or Western blotting
at position 805–807. Correspondingly the 3* noncoding(not shown). Although all seven mAbs, 75–79 and 86–
region of the G mRNAs of strains 220-69, 391-2, and87, recognized both the 127 and the 4642 strains of BRS
Snook were 18 nucleotides shorter than those of strainsvirus in ELISA, only two mAbs, 78 and 86, recognized all
127, 4642, 220-60, and WBH. Variation in the position ofthe subgroup B strains studied (Fig. 1). None of the mAbs
the termination codons has been described for HRS virusreacted with any of the strains previously designated as
(Sullender, 1991) and for other strains of BRS virus (Mal-subgroup A, with intermediate strains, or with the WBH
lipeddi and Samal, 1993).strain (Fig. 1), confirming previous studies of the anti-
genic heterogeneity of the G protein of BRS virus.
Deduced protein sequence analysis
Antibody response of calves vaccinated with rVV-G
The deduced protein sequence was determined from
Antigenic differences in the G protein of BRS virus the nucleotide sequence for each gene and then aligned
strains have also been demonstrated previously using in comparison with the 391-2 strain (Fig. 3). The G mRNA
two hyperimmune polyclonal bovine sera raised against of strains 127, 4642, 220-60, and WBH encoded a major
the 127 and 391-2 strains (Furze et al., 1994). In order to open reading frame of 263 amino acids, 6 amino acids
examine the specificity of the polyclonal antibody re- longer than the major open reading frame encoded by
sponse to the G protein further, sera from calves vacci- the G mRNA of strains 391-2, 220-69, and Snook. All
nated with a rVV expressing the G protein of the 391-2
strain of BRS virus were examined for their ability to react
TABLE 3with four antigenically distinct strains of BRS virus by
ELISA (Table 3). Sera from these vaccinated calves rec- Recognition of Bovine RSV Strains by Sera from Calves Vaccinated
ognized the Snook strain, another subgroup A strain, and with rVV Expressing the F or G Proteins of the 391-2 Strain of BRS
Virusalso the 220-69 strain, an intermediate strain, although
the titer was 10-fold lower. However, the sera failed to
Bovine RSV strainsrecognize either the 127, subgroup B, or the WBH, un-
Vaccinia
typed strain. Nevertheless, mAbs recognizing the G pro- virus Snook (A) 220-69 (Int)a 127 (B) WBH (U)b
tein of the Snook, 127, or 220-69 strains all had ELISA
rV VF 3.6 { 0.2 3.4 { 0.2 3.7 { 0.3 3.3 { 0.3titers greater than log10 6.0 against the respective anti-
rV VG 3.0 { 0.4 2.1 { 0.3 1.5 1.5gens. Furthermore, all BRS virus strains were recognized
by serum from calves vaccinated with a rVV expressing
Note. Log10 ELISA antibody titer, mean { standard deviation ofthe F protein from the 391-2 isolate of BRS virus. Thus, groups of three to five calves.
polyclonal sera from calves vaccinated with rVV express- a Intermediate.
b Untyped.ing the G protein of BRS virus are subgroup-specific.
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FIG. 3. Comparison of the deduced amino acid sequences among the G proteins of BRS virus strains. The sequence for the 391-2 is strain is
shown; for the other strains only residues that differ from the 391-2 strain are shown. The crosses below the sequences are spaced every 10 amino
acid residues and the number of the last residue for each line is shown to the right of the line. The horizontal line above the sequence indicates
the signal/anchor domain. The four conserved cysteine residues are indicated (.). The potential N-linked glycosylation sites are also indicated;
(l) conserved between isolates; (s) nonconserved between isolates.
changes in the deduced protein sequences involved sin- deduced amino acid sequences of all of the BRS virus
strains showed a high level (25%) of serine and threoninegle amino acid changes and no insertions, deletions, or
frameshifts were observed. residues, the potential O-linked carbohydrate acceptor
sites. There were also four potential N-linked glycosyla-HRS virus G proteins and the 391-2 G protein are highly
modified by the addition of N- and O-linked carbohy- tion sites present in the extracellular domain from each
strain, although only the site at amino acid residue 85drates (Gruber and Levine, 1985; Wertz et al., 1985). The
FIG. 2. Nucleotide sequence comparisons among the attachment protein G mRNAs of BRS virus strains as determined from cDNA sequence
analysis. The sequence of the 391-2 G cDNA is shown (Lerch et al., 1990); for other viruses only differences relative to 391-2 are shown. The line
above the sequence indicates the nucleotides covered by the 5* PCR primer. The consensus initiation codon and the termination codons for the
different virus G mRNAs are boxed. The asterisks indicate the deletion mutations. / above the sequences are spaced every 10 nucleotides and
the number of the last nucleotide on the line is indicated to the right of the sequence.
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TABLE 4
Percentages of Nucleotide and Amino Acid Identities for G Genes and Proteins of BRS Virus
Antigenic
subgroups 391-2 Snook 220-69 127 4642 220-60 WBH
A 391-2 95.0 94.5 90.2 90.2 90.2 92.3
A Snook 92.2 (90.0) 96.3 91.6 91.4 92.0 94.8
Int a 220-69 99.2 (90.6) 93.3 (91.6) 92.8 92.8 93.0 94.2
B 127 86.0 (82.2) 85.6 (81.1) 87.9 (84.8) 99.6 96.7 90.9
B 4642 86.0 (82.2) 85.6 (81.1) 87.9 (84.8) 99.2 (99.0) 96.5 90.9
B 220-60 84.8 (81.3) 85.9 (82.2) 87.9 (85.4) 94.6 (93.4) 94.3 (92.3) 91.3
Ub WBH 89.5 (86.4) 91.8 (89.0) 91.4 (89.0) 85.2 (80.7) 85.2 (80.7) 85.2 (81.3)
Note. Nucleotide identities (%) appear above the diagonal rule; amino acid identities (%) appear below the diagonal rule. Data in parentheses
represent amino acid identity in the extracellular domain.
a Intermediate.
b Untyped.
was conserved among all seven strains (Fig. 3). There four amino acid changes were detected in the cyto-
plasmic or the transmembrane domains among the sixwas a high level of proline residues (13%) as noted pre-
viously for both human and bovine G protein sequences. BRS virus strains and 391-2, and the extracellular do-
mains of the G protein varied by less than 20% betweenThere were four cysteine residues in the extracellular
domain of the seven BRS virus strains. The spacing of strains. The amino acid variability is not evenly distrib-
uted through the protein. The first 76 amino acids at thethese residues was identical to that observed with other
BRS virus and HRS virus G glycoproteins (Cane et al., amino terminus, which are conserved, are followed by
amino acids 77–91, which are fairly variable. There is1991; Mallipeddi and Samal, 1993). The 13-amino-acid
sequence preceding the first cysteine residue which is another small conserved area, followed by highly vari-
able domains between amino acids 105 and 136, aminoconserved among both HRS virus subgroups (Johnson
et al., 1987) was not conserved among the BRS virus acids 181 and 196, and amino acids 220 and 247.
strains.
Protein expressionOther features that were conserved between the G
proteins of the BRS virus strains and the HRS virus One of the eventual goals of our studies of BRS virus
strains include a methionine at amino acid residue 48, G proteins is an improved understanding of the structural
which is the initiation site for the shed form of the G features responsible for the antigenic variation. To con-
protein (Roberts et al., 1994), a highly conserved amino firm that the initial antigenic characterization made using
terminal cytoplasmic domain, and an extended hy- virus did map to the G protein and to validate the cloned
drophobic domain from residues 38 to 66, which is the G genes, the G proteins expressed from the cDNAs of
signal/anchor domain (Lichtenstein et al., 1996) (Fig. 3). each gene were analyzed with subgroup-specific hyper-
immune sera and mAbs (Fig. 4). Immunoprecipitation ofSequence comparison
cytoplasmic extracts prepared from cells transfected with
391-2 or the two group B strains, 127 and 4642, demon-The nucleotide and deduced amino acid sequences
for the seven BRSV strains were compared to determine strated that these clones had antigenic reactivity identi-
cal to that of the G proteins produced during infectionthe extent of sequence identity. The seven G mRNA se-
quences varied from only 1 to 10% (Table 4), with the (Furze et al., 1994). As expected, the G proteins from the
127 and 4642 clones reacted with M117 serum (Fig. 4,greatest divergence seen between subgroup A and sub-
group B strains and between subgroup B strains and the lanes 2 and 3), and with mAb 70 (Fig. 4, lanes 10 and
11), while the 391-2 G protein was not recognized byuntyped WBH strain.
The levels of identity among the G proteins of the M117 serum (Fig. 4, lane 4). The G protein expressed
from the 391-2 clone reacted with 2106 serum (Fig. 4,seven BRS virus strains were 85–99%, with the greatest
divergence seen between subgroup A and subgroup B lane 8) and with mAb57 (Fig. 4, lane 13). Both of the
subgroup B G proteins cross-reacted weakly with thestrains and between the 127 strain and the WBH strain.
Two subgroup B strains, 127 and 4642, which were iso- 2106 serum (Fig. 4, lanes 6 and 7), as had been reported
previously for the G proteins produced during infectionslated on different farms in the United Kingdom, 3 years
apart, differed from each other by only one amino acid. with these two virus strains (Furze et al., 1994).
One of two independent clones obtained from the 127Most of the variation between the deduced protein se-
quences was limited to the extracellular domain. Only strain was not recognized by mAb 70, which was raised
AID VY 8490 / 6a31$$$$$3 04-02-97 07:02:42 vira AP: Virology
55G PROTEIN VARIABILITY OF BOVINE RSV SUBGROUPS
FIG. 4. Expression of the BRSV G proteins from cDNA clones. Semiconfluent monolayers of HuTK0143B cells were infected with vTF7-3 and 1
hr later transfected with the cDNA of each of the BRSV G gene clones. The control cells were infected with vTF7-3 and treated with lipofectin, but
did not receive any DNA. Medium containing [3H]glucosamine was added 5 hr after transfection. Cell extracts were immunoprecipitated with the
polyclonal sera M117 (lanes 1 –4) or 2106 (lanes 5–8) or with mAbs 70 (lanes 9–11) or 57 (lanes 12 and 13). The precipitated proteins were
analyzed by SDS–PAGE on 10% polyacrylamide gels. Mock-transfected cells (lanes 1, 5, 9, and 12); cells transfected with BRS virus strain 127
(lanes 2, 6, and 10); cells transfected with strain 4642 (lanes 3, 7, and 11) and cells transfected with strain 391-2 (lanes 4, 8, and 13).
against the 127 strain, although the protein was recog- the region 174–188 of the 391-2 G protein as well as to
the peptide corresponding to this region of the 220-69 Gnized by the polyclonal serum M117 (data not shown).
Comparison of the nucleotide sequence of this clone protein (Fig. 5). Of the 7 mAbs that react only with sub-
group A viruses and not with the intermediate strains,with the nucleotide sequence of a second 127 clone that
expressed a G protein that was recognized by mAb 70 two, mAbs 47 and 57, failed to react with the peptide
from either strain, while four, mAbs 62, 46, 53, and 69,revealed a difference at nucleotide 631. This nucleotide
difference results in an amino acid change from a lysine recognized the 391-2 peptide but not the 220-69 peptide,
and one mAb, 61, reacted weakly with peptides fromat amino acid residue 209 in the G protein recognized
by mAb 70 to a gluramic acid in the unreactive protein. both 391-2 and 220-69. None of the mAbs raised against
the 127 G protein reacted with any of the peptides andAt present there are no polyclonal or monoclonal anti-
bodies which react with the G protein from the WBH the WBH peptide was not recognized by any of the mAbs.
These studies highlight the importance of the cysteine-strain. Therefore to confirm that a G protein was ex-
pressed from this clone, total cytoplasmic extracts from rich region in recognition of BRS virus subgroups by
mAbs.untransfected cells and from cells transfected with the
4642 clone and the WBH clone labeled in the presence of
[3H]glucosamine were compared. A highly glycosylated DISCUSSION
protein was detected in the cytoplasmic extracts pre-
The genetic variability of the two antigenically distinctpared from cells transfected with the WBH clone which
subgroups of HRS virus has been well characterizedcomigrated with the G protein from the cells transfected
(Cane and Pringle, 1991; Johnson et al., 1987; Sullenderwith the 4642 clone (data not shown). No glycosylated
et al., 1991). However, the limited genetic analysis of theprotein was detected at this molecular weight in the ex-
G genes of BRS virus strains to date has suggestedtract from the mock-transfected cells. Additionally, this
that this virus is monotypic (Mallipeddi and Samal, 1993).protein could not be immunoprecipitated with either the
Recently, an analysis of the antigenic relatedness of aM117 or the 2106 sera (data not shown).
large number of BRS virus strains has demonstrated the
presence of at least two BRS virus subgroups (Furze etBinding of antibodies to synthetic peptides
al., 1994). In the work reported here, we have examined
the genetic basis for the antigenic heterogeneity of theAkerlind-Stopner et al. (1990) identified amino acids
174–188, which comprises the cysteine-rich region, as BRS virus G protein. The divergence among the G pro-
teins of the seven BRS virus strains analyzed here, whichrepresenting an important HRS virus subgroup-specific
site. Therefore, we examined mAbs that distinguish are representative of the antigenic groups, was much
lower in comparison to the variability observed betweenstrains of BRS virus for their ability to react with peptides
corresponding to amino acid 174 to 188 of the G protein the two HRS virus subgroups. Thus, there was up to 15%
variability in the deduced amino acid sequence betweenfrom four BRS virus strains. In this region, 11 of the resi-
dues are conserved, as is the spacing of the cysteine BRS virus G proteins, whereas there is 47% variability in
the G proteins between the prototype strains of the tworesidues among the four strains. However, amino acids
at four positions, residues 180, 183, 184, and 187, vary subgroups of HRS virus (Johnson et al., 1987). In fact
the extent of amino acid difference between BRS virus(see Table 2).
The 15 mAbs that react with both the 391-2 and the subgroups is similar to that seen within subgroups of
HRS virus (Cane et al., 1991; Sullender et al., 1991).220-69 strains reacted with a peptide corresponding to
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In the BRS virus strains studied here, there was amino
acid variation at only four positions in the cysteine-rich
region of the G protein. Three of these, at positions 180,
183, and 184, appear to be important for the antigenic
reactivity of these strains. These residues also differ be-
tween subgroup A and B HRS virus strains (Akerlind-
Stopner et al., 1990) and a synthetic peptide correspond-
ing to amino acids 174–188 of HRS virus reacted with
subgroup-specific anti-G mAbs (Norrby et al., 1987). Pre-
vious studies showed that the epitopes recognized by
mAbs 44 to 69 overlapped extensively (Furze et al., 1994).
The close relationship of the epitopes recognized by
these mAbs is confirmed by the finding that they all bind
to a synthetic peptide corresponding to the region 174–
188 of the 391-2 strain G protein. Differences in epitope
recognition by the mAbs are probably due to differences
in the contributions made by individual amino acids
within the peptide to antibody binding.
Binding of antibodies to the region 174–188 of the G
protein broadly correlated with their reactivity to strains
from the different BRS virus subgroups. Thus, the 15
mAbs that recognized both subgroup A and intermediate
viruses reacted with peptide 174–188 of both the 391-2
and the intermediate strain, 220-69, which differ only at
amino acids 183 and 187. However mAbs 46, 53, 62, and
69, which recognize only subgroup A viruses, including
both 391-2 and Snook, did not bind to the peptide from
the 220-69 strain. Since the Snook strain differs from 220-
69 only at position 183 in the region 174–188, it is likely
that the loss of binding of these three mAbs is due to
the substitution of serine for leucine at this position in the
FIG. 5. Binding of antibodies to synthetic peptides. G mAbs were intermediate strain. None of the anti-391-2 mAbs which
assayed in an ELISA against peptide 174–188 from four BRS virus recognized the 174–188 peptide corresponding to the
isolates. Patterns: more than 50% (j), 25–50% (¿), and less than 25%
220-69 G peptide bound to the WBH peptide, although(h) of the values obtained for antibody against BRS virus antigen. A
these peptides differ only at amino acid 180. Thus, theto E, competition groups of the mAbs (Furze et al., 1994). ND, competi-
tion group not determined. replacement of lysine at this position in the 220-69 G
peptide by proline in the WBH G protein results in the
loss of binding by these mAbs. These findings highlightThe WBH strain, which is not reactive with any of the
the importance of amino acids at positions 180 and 183available mAbs against the G protein or with polyclonal
in determining the antigenic subgrouping of BRS virussera of subgroup A or subgroup B BRS viruses, was
strains described previously (Furze et al., 1994).nevertheless 9 and 15% divergent with the representa-
The G proteins of the three subgroup B strains studiedtives of subgroup A and subgroup B, respectively. De-
here all have a proline at position 184, whereas the Gspite the high degree of amino acid identity between BRS
proteins of all other strains studied have a serine at thisvirus strains, polyclonal sera from hyperimmune calves
position. This is the only difference between the 174–recognize only the G protein of strains belonging to the
188 peptides of the 127 and WBH G proteins. Althoughhomologous subgroup by immunoprecipitation. Further-
the anti-391-2 mAbs 47 and 57 failed to react with themore, sera from calves vaccinated with rVV-G from the
peptide corresponding to the 391-2 strain, they did react391-2 strain recognizes only subgroup A strains and to
weakly with the corresponding peptide of the 127 strain,a lesser extent the intermediate strain. Thus our genetic
but not with that of the WBH peptide, suggesting that theanalysis combined with the previous antigenic analysis
amino acid at position 184 may also be important inof these strains (Furze et al., 1994) suggests that although
recognition by antibody.the genetic variation responsible for antigenic differ-
Although none of the subgroup B-specific G mAbs rec-ences among BRS virus subgroups is more limited than
ognized any of the peptides corresponding to the regionthat observed among HRS virus subgroups, the amino
174–188 of the G protein, a mutation at amino acid 209acid differences that exist have a profound effect upon
antibody recognition. of lysine to gluramic acid resulted in the loss of reactivity
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transient expression system based on recombinant vaccinia virusof mAb 70 with the G protein, suggesting that this region
that synthesises bacteriophage T7 RNA polymerase. Proc. Natl.of the G protein may also be involved in mAb recognition.
Acad. Sci. USA 83, 8122–8126.
The region corresponding to residues 204 to 209 has Furze, J., Wertz, G. W., Lerch, R., and Taylor, G. (1994). Antigenic hetero-
been identified as a linear epitope on the G protein of geneity of the attachment protein of bovine respiratory syncytial virus.
J. Gen. Virol. 75, 363–370.subgroup A HRS viruses (Garcia et al., 1994). In this
Garcı´a, O., Martı´n, M., Dopazo, J., Arbiza, J., Frabasile, S., Russi, J.,region of the G protein of BRS virus, strains that are
Hortal, M., Perez-Bren˜a, P., Martı´nez, I., Garcı´a-Barreno, B., and Mel-recognized by mAb 70 differ from those that are not rec-
ero, J. A. (1994). Evolutionary pattern of human respiratory syncytial
ognized by a replacement of A to T at position 205, sug- virus (subgroup A): Cocirculating lineages and correlation of genetic
gesting that this substitution may also determine recogni- and antigenic changes in the G protein. J. Virol. 68, 5448–5459.
Garcia-Barreno, B., Delgado, T., Akerlind-Stopner, B., Norrby, E., andtion by mAb 70. This suggestion has been confirmed
Melero, J. A. (1992). Location of the epitope recognised by mono-using synthetic peptides (Langedijk et al., in preparation).
clonal antibody 63G on the primary structure of human respiratoryIn conclusion, although there is a high degree of amino
syncytial virus G glycoprotein and the ability of synthetic peptides
acid identity in the G protein among strains of BRS virus, containing this epitope to induce neutralizing antibodies. J. Gen. Virol.
the amino acid differences that are present have a pro- 73, 2625–2630.
Gruber, C., and Levine, S. (1985). Respiratory syncytial virus polypep-found effect on its antigenicity. Furthermore the finding
tides. IV. The oligosaccharides of the glycoproteins. J. Gen. Virol. 66,that vaccination with rVV expressing the G protein in-
417–432.duces a subgroup-specific antibody response is similar
Hendry, R. M., Talis, A. L., Godfrey, E., Anderson, L. J., Fernie, B. F., and
to that observed with rVV expressing G proteins of HRS McIntosh, K. (1986). Concurrent circulation of antigenically distinct
virus subgroups (Stott et al., 1986; Sullender and Britt, strains of respiratory syncytial virus during community outbreaks. J.
Infect. Dis. 153, 291–297.1996) and may have important consequences for the de-
Johnson, P. R., Spriggs, M. K., Olmstead, R. A., and Collins, P. L. (1987).sign of vaccines against BRS virus.
The G glycoprotein of human respiratory syncytial viruses of sub-
groups A and B: Extensive sequence divergence between antigeni-
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